O. Dohr, R. Hofmeister, M. Treher and H. Schweinfurth, “Preclinical Safety Evaluation of Gd-EOB-DTPA (Pri- movist),” Investigative Radiololgy, Vol. 42, No. 12, 2007, pp. 830-841. doi.org/10.1097/RLI.0b013e318137a471

has been cited by the following article:

• TITLE: PrimavistTM in the Diagnosis of Oxaliplatin Induced Sinusoidal Obstruction: a Case Report

  AUTHORS: Mansoor Ali Khan, Tony Blakeborough, Nick Tiffin, Ahmed Al-Mukhtar

  KEYWORDS: Oxaliplatin, Sinusoidal Obstruction, Liver Injury

  JOURNAL NAME: Journal of Cancer Therapy, Vol.2 No.3, August 8, 2011

  ABSTRACT: This is a case report of a patient who underwent Oxaliplatin based neo-adjuvant chemotherapy for colorectal liver metastases, and subsequently developed sinusoidal obstruction, which was detected by Primavist enhanced MRI scan.